NCT02109042 - A Study of Blosozumab (LY2541546) in Postmenopausal Female Participants | Biotech Hunter

Enrollment

15

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

July 31, 2014

Study Completion Date

July 31, 2014

Conditions

Osteoporosis, Postmenopausal

Interventions

DRUG

Blosozumab

Administered subcutaneously

Trial Locations (2)

32117

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Daytona Beach

75247

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Dallas